Gracell
is a China-based biopharmaceutical company that researches and develops CAR-T cell therapies for the treatment of cancer and autoimmune diseases... Read moreGracell
is a China-based biopharmaceutical company that researches and develops CAR-T cell therapies for the treatment of cancer and autoimmune diseases... Read more
News
Nov 06, 2024
BioCentury
Gracell: Dealmaking in a drought crowns Gracell, Proteologix BayHelix winners
Jun 18, 2024
Yicai Global
Gracell: AstraZeneca's Unit Gracell Biotech to Expand Its Production Facility in China's Suzhou
Feb 24, 2024
Pharmabiz
Gracell: AstraZeneca completes acquisition of clinicalstage biopharma company, Gracell Biotechnologies
Feb 21, 2024
Marketscreener
Gracell: Gracell Biotechnologies Announces Shareholders Approval of Merger Agreement
Feb 20, 2024
MarketScreener
Gracell: Gracell Biotechnologies Announces Shareholders' Approval of Merger Agreement
Jan 12, 2024
Global Legal Chronicle
Gracell: AstraZeneca's $1.2 Billion Acquisition of Gracell Biotechnologies
Jan 02, 2024
MarketScreener
Gracell: Gracell Biotechnologies : Investor Frequently Asked Questions, dated December 29, 2023 - Form 6-K
Jan 02, 2024
PMLiVE
Gracell: AstraZeneca to acquire cell therapy specialist Gracell in deal worth up to $1.2bn
Dec 29, 2023
Benzinga
Gracell: 2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
Dec 28, 2023
Post Online Media
Gracell: AstraZeneca aquires Gracell Biotechnologies for up to $1.2 billion
Gracell Competitors
1
2
3
4
5
6
7
8
9
10